Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle

Breast Cancer Research and Treatment

Volumn 38, Issue 2, 1996, Pages 227-235

  Gompel, A ^a   Martin, A ^a   Simon, P ^a   Schoevaert D ^b   Plu Bureau, G ^c   Hugol, D ^a   Audouin, J ^a   Leygue, E ^c   Truc, J B ^a   Poitout, Ph ^a  

^a HÔTEL DIEU   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

c erbB 2; EGF receptor; Image analyser; Menstrual cycle; Normal breast

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBROADENOMA; FOLLICULAR PHASE; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MENSTRUAL CYCLE; MYOEPITHELIUM CELL; NORMAL HUMAN; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS;

BREAST; BREAST NEOPLASMS; FEMALE; FIBROADENOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS;

EID: 9244238211     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806677     Document Type: Article

References (37)

1. Dickson RB, Lippman ME: Estrogen regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Reviews 8: 29-43, 1986
2. Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR, Mendelsohn J, Lippman ME, Dickson R: Expression of the transforming growth factor-α-epidermal growth receptor pathway in normal human breast epithelial cells. Endocrinology 126: 596-607, 1990
3. Derynck R: Transforming growth factor α. Cell 54: 593-595, 1988
4. Damjanov I, Mildner B, Knowles DBB: Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 55: 588-592, 1986
5. Velu TJ: Structure, function and transforming potential of the epidermal growth factor (review). Mol Cell Endoc 70: 205-216, 1990
6. Sainsbury JRC, Malcolm AJ, Appleton DR, Farndon JR, Harris AL: Presence of epidermal growth factor receptor as an indicator of prognosis in patients with breast cancer. J Clin Path 38: 1225-1228, 1985
7. Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 44: 3348-3353, 1984
8. Murphy LJ, Sutherland RL, Stead B, Murphy LC, Laganes L: Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res 46: 728-734, 1986
9. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Lerang WJ, Wood WI, Goeddel DAV, Vandlen RL: Identification of heregulin, a specific activator of p185 erbB-2. Science 256: 1205-1209, 1992
10. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y: Isolation of the Neu/Her-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216, 1992
11. c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proc Natl Acad Sci 89: 1330-1334, 1992
12. Spivak-Kroizman R, Rotin D, Pinchasi D, Ullrich A, Schelninger J, Lax I: Heterodimerization of c-erbB-2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses. J Biol Chem 267: 8056-8063, 1992
13. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA: erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 230: 1854-1866, 1987
14. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
15. Guérin M, Gubillot M, Mathieu MC, Trangli JP, Spielmann M, Andrieu N, Riou G: Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer 43: 201-208, 1989
16. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P: Single step induction of mammary adenocarcinoma in transgenic mice bearing activated c-neu oncogene. Cell 54: 105-115, 1988
17. Pierce JH, Arnstein P, Di Marco E, Artaip J, Kraus MH, Leonardo F, Di Fiore PP, Aaronson SA: Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189-1194, 1991
18. Dati C, Antoniotti S, Taverna P, Perrotan I, De Bortoli M: Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5: 1001-1006, 1990
19. Read LD, Keith D, Slamon DJ, Katzenellenbogen BS: Hormonal modulation of HER-2/neu proto-oncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res 50: 3937-3951, 1990
20. Russell KS, Hung M-C: Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Cancer Res 52: 6624-6629, 1992
21. Bacus SS, Kiguchi K, Chin D, King CR, Huberman E: Differentiation of cultured human breast cancer cells (Au-565 and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol Carcinog 3: 350-362, 1990
22. Tsutsumi Y, Naber SP, De Lellis RA, Wolfe HJ, Marks PL, McKenzie SJ, Yin S: Neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum Pathol 21: 750-758, 1990
23. Barker S, Panahy C, Puddefoot JR, Goode AW, Vinson GP: Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast. Br J Cancer 60: 673-677, 1989
24. Wang D, Fuji S, Konishi I, Nambu Y, Iwai T, Nonogaki H: Expression of c-erbR-2 protein and epidermal growth factor receptor in normal tissues of the genital tract and in the placenta. Virchows Archiv A Pathol Anat 420: 385-393, 1992
25. Giudice LC: Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 61: 1-17, 1994
26. Press MF, Cordon-Cardo C, Slamon DJ: Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5: 953-962, 1990
27. Kraus MJ, Popescu NC, Amsbaugh SC, King LR: Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605-610, 1987
28. Dittadi R, Donisi M, Brazzale A, Cappelloza L, Bruscagnin G, Gion M: Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue. Br J Cancer 67: 7-9, 1993
29. Wärri AM, Laine AM, Majasuo KE, Alitalo KK, Harkonen PL: Estrogen suppression of erbB-2 is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice. Int J Cancer 49: 616-623, 1991
30. Taverna D, Antonietti S, Maggiora P, Dati C, De Bortoli M, Hynes NE: erbB-2 expression in estrogen receptor positive breast tumor cells is regulated by growth modulatory reagents. Int J Cancer 56: 522-528, 1994
31. Marth C, Lang T, Cronauer MV, Doppler W, Zeimet AG, Bachmair F, Ullrich A, Daxenbichler M: Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells. Int J Cancer 52: 311-316, 1992
32. Dougall WC, Qian X, Creene MI: Interaction of the Neu/ p185 and EGF-R tyrosine kinases: implications for cellular transformation and tumor therapy. J Cell Biochem 53: 61-73, 1993
33. Bradbury JM, Arno J, Edwards AW: Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland. Oncogene 8: 1551-1558, 1993
34. Kornilova ES, Taverna D, Hoeck W, Hynes NE: Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. Oncogene 7: 511-519, 1992
35. Gardner GM, Vernier G, Kirkland JL, Stancel GM: Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J Steroid Biochem 32: 339-343, 1989
36. Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181, 1981
37. Longacre TA, Bartow SA: A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382-393, 1986